Kristina Carlson

The impact of DNMT3A mutation on survival of AML patients receiving allotransplant in first remission depends on the karyotype and co-occurring mutations

Abou Dalle, Iman; Galimard, Jacques-Emmanuel; Poire, Xavier; Sanz, Jaime et al.

Ingår i Bone Marrow Transplantation, s. 326-332, 2026

• DOI för The impact of DNMT3A mutation on survival of AML patients receiving allotransplant in first remission depends on the karyotype and co-occurring mutations

Posttransplant cyclophosphamide versus antithymocyte globulin in patients with cardiovascular comorbidity undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukaemia in first complete remission from unrelated donors: a retrospective matched-pair analysis from the ALWP of the EBMT

Vydra, Jan; Ferhat, Allain-Thibeault; Kröger, Nicolaus; Gedde-Dahl, Tobias et al.

Ingår i Bone Marrow Transplantation, s. 206-210, 2026

• DOI för Posttransplant cyclophosphamide versus antithymocyte globulin in patients with cardiovascular comorbidity undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukaemia in first complete remission from unrelated donors: a retrospective matched-pair analysis from the ALWP of the EBMT
• Ladda ner fulltext (pdf) av Posttransplant cyclophosphamide versus antithymocyte globulin in patients with cardiovascular comorbidity undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukaemia in first complete remission from unrelated donors: a retrospective matched-pair analysis from the ALWP of the EBMT

Adding Bortezomib and Bendamustine to High-Dose Melphalan in Autologous Haematopoietic Stem Cell Transplantation for Relapsed Multiple Myeloma-A Single Centre Retrospective Study

Silfverberg, Thomas; Cherif, Honar; Smitt, Emma; Carlson, Kristina

Ingår i eJHaem, 2026

• DOI för Adding Bortezomib and Bendamustine to High-Dose Melphalan in Autologous Haematopoietic Stem Cell Transplantation for Relapsed Multiple Myeloma-A Single Centre Retrospective Study
• Ladda ner fulltext (pdf) av Adding Bortezomib and Bendamustine to High-Dose Melphalan in Autologous Haematopoietic Stem Cell Transplantation for Relapsed Multiple Myeloma-A Single Centre Retrospective Study

Risk of infections in multiple myeloma: A populationbased study on 8,672 multiple myeloma patients diagnosed 2008-2021 from the Swedish Myeloma Registry

Hveding Blimark, Cecilie; Carlson, Kristina; Day, Christopher; Einarsdottir, Sigrun et al.

Ingår i Haematologica, s. 163-172, 2025

• DOI för Risk of infections in multiple myeloma: A populationbased study on 8,672 multiple myeloma patients diagnosed 2008-2021 from the Swedish Myeloma Registry
• Ladda ner fulltext (pdf) av Risk of infections in multiple myeloma: A populationbased study on 8,672 multiple myeloma patients diagnosed 2008-2021 from the Swedish Myeloma Registry

BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party

Greco, Raffaella; Saccardi, Riccardo; Ponzano, Marta; Badoglio, Manuela et al.

Ingår i Bone Marrow Transplantation, s. 1628-1634, 2025

• DOI för BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party
• Ladda ner fulltext (pdf) av BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party

The impact of DNMT3A mutation on survival of AML patients receiving allotransplant in first remission depends on the karyotype and co-occurring mutations

Abou Dalle, Iman; Galimard, Jacques-Emmanuel; Poire, Xavier; Sanz, Jaime et al.

Ingår i Bone Marrow Transplantation, s. 326-332, 2026

• DOI för The impact of DNMT3A mutation on survival of AML patients receiving allotransplant in first remission depends on the karyotype and co-occurring mutations

Posttransplant cyclophosphamide versus antithymocyte globulin in patients with cardiovascular comorbidity undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukaemia in first complete remission from unrelated donors: a retrospective matched-pair analysis from the ALWP of the EBMT

Vydra, Jan; Ferhat, Allain-Thibeault; Kröger, Nicolaus; Gedde-Dahl, Tobias et al.

Ingår i Bone Marrow Transplantation, s. 206-210, 2026

• DOI för Posttransplant cyclophosphamide versus antithymocyte globulin in patients with cardiovascular comorbidity undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukaemia in first complete remission from unrelated donors: a retrospective matched-pair analysis from the ALWP of the EBMT
• Ladda ner fulltext (pdf) av Posttransplant cyclophosphamide versus antithymocyte globulin in patients with cardiovascular comorbidity undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukaemia in first complete remission from unrelated donors: a retrospective matched-pair analysis from the ALWP of the EBMT

Adding Bortezomib and Bendamustine to High-Dose Melphalan in Autologous Haematopoietic Stem Cell Transplantation for Relapsed Multiple Myeloma-A Single Centre Retrospective Study

Silfverberg, Thomas; Cherif, Honar; Smitt, Emma; Carlson, Kristina

Ingår i eJHaem, 2026

• DOI för Adding Bortezomib and Bendamustine to High-Dose Melphalan in Autologous Haematopoietic Stem Cell Transplantation for Relapsed Multiple Myeloma-A Single Centre Retrospective Study
• Ladda ner fulltext (pdf) av Adding Bortezomib and Bendamustine to High-Dose Melphalan in Autologous Haematopoietic Stem Cell Transplantation for Relapsed Multiple Myeloma-A Single Centre Retrospective Study

Risk of infections in multiple myeloma: A populationbased study on 8,672 multiple myeloma patients diagnosed 2008-2021 from the Swedish Myeloma Registry

Hveding Blimark, Cecilie; Carlson, Kristina; Day, Christopher; Einarsdottir, Sigrun et al.

Ingår i Haematologica, s. 163-172, 2025

• DOI för Risk of infections in multiple myeloma: A populationbased study on 8,672 multiple myeloma patients diagnosed 2008-2021 from the Swedish Myeloma Registry
• Ladda ner fulltext (pdf) av Risk of infections in multiple myeloma: A populationbased study on 8,672 multiple myeloma patients diagnosed 2008-2021 from the Swedish Myeloma Registry

BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party

Greco, Raffaella; Saccardi, Riccardo; Ponzano, Marta; Badoglio, Manuela et al.

Ingår i Bone Marrow Transplantation, s. 1628-1634, 2025

• DOI för BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party
• Ladda ner fulltext (pdf) av BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party

Factors associated with outcomes following autologous haematopoietic stem cell transplantation for multiple sclerosis

Noui, Yassine; Zjukovskaja, Christina; Silfverberg, Thomas; Ljungman, Per et al.

Ingår i Journal of Neurology, Neurosurgery and Psychiatry, s. 966-974, 2025

• DOI för Factors associated with outcomes following autologous haematopoietic stem cell transplantation for multiple sclerosis
• Ladda ner fulltext (pdf) av Factors associated with outcomes following autologous haematopoietic stem cell transplantation for multiple sclerosis

Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosis

Hernandez-Boluda, Juan Carlos; Mosquera-Orgueira, Adrian; Gras, Luuk; Koster, Linda et al.

Ingår i Blood, s. 3139-3152, 2025

• DOI för Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosis

Tuberculosis after hematopoietic cell transplantation: retrospective study on behalf of the infectious diseases working party of the EBMT

Drozd-Sokolowska, Joanna; Tridello, Gloria; Verheggen, Inge; Karakukcu, Musa et al.

Ingår i Bone Marrow Transplantation, s. 603-616, 2025

• DOI för Tuberculosis after hematopoietic cell transplantation: retrospective study on behalf of the infectious diseases working party of the EBMT

Income and education affect prognosis and treatment in symptomatic myeloma

Larfors, Gunnar; Carlson, Kristina; Day, Christopher; Einarsdottir, Sigrun et al.

Ingår i Annals of Hematology, s. 565-572, 2025

• DOI för Income and education affect prognosis and treatment in symptomatic myeloma
• Ladda ner fulltext (pdf) av Income and education affect prognosis and treatment in symptomatic myeloma

Patient-reported outcomes of quality of life before and after autologous hematopoietic stem cell transplantation for multiple sclerosis

Mitrache Desaga, Ann-Christine; Noui, Yassine; Silfverberg, Thomas; Carlson, Kristina et al.

Ingår i Multiple Sclerosis Journal, s. 455-463, 2025

• DOI för Patient-reported outcomes of quality of life before and after autologous hematopoietic stem cell transplantation for multiple sclerosis
• Ladda ner fulltext (pdf) av Patient-reported outcomes of quality of life before and after autologous hematopoietic stem cell transplantation for multiple sclerosis

Ixazomib, Lenalidomide, and Dexamethasone (IRD) Treatment with Cytogenetic Risk-Based Maintenance in Transplant-Eligible Myeloma: A Phase 2 Multicenter Study by the Nordic Myeloma Study Group

Partanen, Anu; Waage, Anders; Peceliunas, Valdas; Schjesvold, Fredrik et al.

Ingår i Cancers, s. 1024-1024, 2024

• DOI för Ixazomib, Lenalidomide, and Dexamethasone (IRD) Treatment with Cytogenetic Risk-Based Maintenance in Transplant-Eligible Myeloma: A Phase 2 Multicenter Study by the Nordic Myeloma Study Group
• Ladda ner fulltext (pdf) av Ixazomib, Lenalidomide, and Dexamethasone (IRD) Treatment with Cytogenetic Risk-Based Maintenance in Transplant-Eligible Myeloma: A Phase 2 Multicenter Study by the Nordic Myeloma Study Group

Hematopoietic stem cell transplantation for pediatric patients with non-anaplastic peripheral T-cell lymphoma. An EBMT pediatric diseases working party study

Moser, Olga; Ngoya, Maud; Galimard, Jacques-Emmanuel; Dalissier, Arnaud et al.

Ingår i Bone Marrow Transplantation, s. 604-614, 2024

• DOI för Hematopoietic stem cell transplantation for pediatric patients with non-anaplastic peripheral T-cell lymphoma. An EBMT pediatric diseases working party study
• Ladda ner fulltext (pdf) av Hematopoietic stem cell transplantation for pediatric patients with non-anaplastic peripheral T-cell lymphoma. An EBMT pediatric diseases working party study

Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study

Silfverberg, Thomas; Zjukovskaja, Christina; Ljungman, Per; Nahimi, Adjmal et al.

Ingår i Journal of Neurology, Neurosurgery and Psychiatry, s. 125-133, 2024

• DOI för Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study
• Ladda ner fulltext (pdf) av Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study

BEAM or cyclophosphamide in autologous haematopoietic stem cell transplantation for relapsing-remitting multiple sclerosis

Silfverberg, Thomas; Zjukovskaja, Christina; Noui, Yassine; Carlson, Kristina et al.

Ingår i Bone Marrow Transplantation, s. 1601-1610, 2024

• DOI för BEAM or cyclophosphamide in autologous haematopoietic stem cell transplantation for relapsing-remitting multiple sclerosis
• Ladda ner fulltext (pdf) av BEAM or cyclophosphamide in autologous haematopoietic stem cell transplantation for relapsing-remitting multiple sclerosis

Human Leukocyte Antigen Mismatching and Survival in Contemporary Hematopoietic Cell Transplantation for Hematologic Malignancies

Arrieta-Bolaños, Esteban; Bonneville, Edouard F.; Crivello, Pietro; Robin, Marie et al.

Ingår i Journal of Clinical Oncology, s. 3287-3299, 2024

• DOI för Human Leukocyte Antigen Mismatching and Survival in Contemporary Hematopoietic Cell Transplantation for Hematologic Malignancies

Risk factors for Nocardia infection among allogeneic hematopoietic cell transplant recipients: A case-control study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation

De Greef, Julien; Averbuch, Dina; Tondeur, Laura; Duréault, Amélie et al.

Ingår i Journal of Infection, 2024

• DOI för Risk factors for Nocardia infection among allogeneic hematopoietic cell transplant recipients: A case-control study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation
• Ladda ner fulltext (pdf) av Risk factors for Nocardia infection among allogeneic hematopoietic cell transplant recipients: A case-control study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation

Graft-versus-Host Disease Prophylaxis with PostTransplantation Cyclophosphamide in Chronic Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation from an Unrelated or Mismatched Related Donor: A Comparative Study from the Chronic Malignancies Working Party of the EBMT (CMWP-EBMT)

Ortí, Guillermo; Gras, Luuk; Koster, Linda; Kulagin, Aleksander et al.

Ingår i Transplantation and Cellular Therapy, s. 930-93000000000000, 2024

• DOI för Graft-versus-Host Disease Prophylaxis with PostTransplantation Cyclophosphamide in Chronic Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation from an Unrelated or Mismatched Related Donor: A Comparative Study from the Chronic Malignancies Working Party of the EBMT (CMWP-EBMT)

Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19: An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry

Ljungman, Per; Tridello, Gloria; Pinana, Jose Luis; Ciceri, Fabio et al.

Ingår i Frontiers in Immunology, 2023

• DOI för Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19: An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry
• Ladda ner fulltext (pdf) av Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19: An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry

Anti-Müllerian hormone and pregnancy after autologous hematopoietic stem cell transplantation for multiple sclerosis

Zafeiri, Lida; Åkerfeldt, Torbjörn; Tolf, Andreas; Carlson, Kristina et al.

Ingår i PLOS ONE, 2023

• DOI för Anti-Müllerian hormone and pregnancy after autologous hematopoietic stem cell transplantation for multiple sclerosis
• Ladda ner fulltext (pdf) av Anti-Müllerian hormone and pregnancy after autologous hematopoietic stem cell transplantation for multiple sclerosis

Impact of daratumumab-based induction on stem cell collection parameters in Swedish myeloma patients

Lemonakis, Konstantinos; Tätting, Love; Lisak, Mikael; Carlson, Kristina et al.

Ingår i Haematologica, s. 610-614, 2023

• DOI för Impact of daratumumab-based induction on stem cell collection parameters in Swedish myeloma patients
• Ladda ner fulltext (pdf) av Impact of daratumumab-based induction on stem cell collection parameters in Swedish myeloma patients

Fludarabine/TBI 8 Gy versus fludarabine/treosulfan conditioning in patients with AML in first complete remission: a study from the Acute Leukemia Working Party of the EBMT

Bug, Gesine; Labopin, Myriam; Niittyvuopio, Riitta; Stelljes, Matthias et al.

Ingår i Bone Marrow Transplantation, s. 710-716, 2023

• DOI för Fludarabine/TBI 8 Gy versus fludarabine/treosulfan conditioning in patients with AML in first complete remission: a study from the Acute Leukemia Working Party of the EBMT
• Ladda ner fulltext (pdf) av Fludarabine/TBI 8 Gy versus fludarabine/treosulfan conditioning in patients with AML in first complete remission: a study from the Acute Leukemia Working Party of the EBMT

Impact of COVID-19 on patients treated with autologous hematopoietic stem cell transplantation: A retrospective cohort study

Silfverberg, Thomas; Wahlin, Bjorn; Carlson, Kristina; Cherif, Honar

Ingår i Upsala Journal of Medical Sciences, 2022

• DOI för Impact of COVID-19 on patients treated with autologous hematopoietic stem cell transplantation: A retrospective cohort study
• Ladda ner fulltext (pdf) av Impact of COVID-19 on patients treated with autologous hematopoietic stem cell transplantation: A retrospective cohort study

Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group

Gregersen, Henrik; Peceliunas, Valdas; Remes, Kari; Schjesvold, Fredrik et al.

Ingår i European Journal of Haematology, s. 34-44, 2022

• DOI för Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group
• Ladda ner fulltext (pdf) av Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group

Allogeneic hematopoietic stem cell transplantation for adult HLH: a retrospective study by the chronic malignancies and inborn errors working parties of EBMT

Machowicz, Rafal; Suarez, Felipe; Wiktor-Jedrzejczak, Wieslaw; Eikema, Diderik-Jan et al.

Ingår i Bone Marrow Transplantation, s. 817-823, 2022

• DOI för Allogeneic hematopoietic stem cell transplantation for adult HLH: a retrospective study by the chronic malignancies and inborn errors working parties of EBMT

Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing-remitting multiple sclerosis: an observational study

Zhukovsky, Christina; Sandgren, Sofia; Silfverberg, Thomas; Einarsdottir, Sigrun et al.

Ingår i Journal of Neurology, Neurosurgery and Psychiatry, s. 189-194, 2021

• DOI för Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing-remitting multiple sclerosis: an observational study
• Ladda ner fulltext (pdf) av Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing-remitting multiple sclerosis: an observational study

Quantification of (11)C-PIB kinetics in cardiac amyloidosis

Kero, Tanja; Sörensen, Jens; Antoni, Gunnar; Wilking, Helena et al.

Ingår i Journal of Nuclear Cardiology, s. 774-784, 2020

• DOI för Quantification of (11)C-PIB kinetics in cardiac amyloidosis
• Ladda ner fulltext (pdf) av Quantification of (11)C-PIB kinetics in cardiac amyloidosis

Diagnostic Accuracy of [¹¹C]PIB Positron Emission Tomography for Detection of Cardiac Amyloidosis

Rosengren, Sara; Skibsted Clemmensen, Tor; Tolbod, Lars; Granstam, Sven-Olof et al.

Ingår i JACC Cardiovascular Imaging, s. 1337-1347, 2020

• DOI för Diagnostic Accuracy of [¹¹C]PIB Positron Emission Tomography for Detection of Cardiac Amyloidosis

Intrathecal immunoglobulins and neurofilament light after autologous haematopoietic stem cell transplantation for multiple sclerosis

Larsson, Diane; Åkerfeldt, Torbjörn; Carlson, Kristina; Burman, Joachim

Ingår i Multiple Sclerosis Journal, s. 1351-1359, 2020

• DOI för Intrathecal immunoglobulins and neurofilament light after autologous haematopoietic stem cell transplantation for multiple sclerosis

Outcome and characteristics of non-measurable myeloma: A cohort study with population-based data from the Swedish Myeloma Registry

Wålinder, Göran; Samuelsson, Jan; Näsman, Per; Hansson, Markus et al.

Ingår i European Journal of Haematology, s. 376-382, 2020

• DOI för Outcome and characteristics of non-measurable myeloma: A cohort study with population-based data from the Swedish Myeloma Registry

Sustained remission in multiple sclerosis after hematopoietic stem cell transplantation

Tolf, Andreas; Fagius, Jan; Carlson, Kristina; Åkerfeldt, Torbjörn et al.

Ingår i Acta Neurologica Scandinavica, s. 320-327, 2019

• DOI för Sustained remission in multiple sclerosis after hematopoietic stem cell transplantation

High Graft-versus-Host Disease-Free, Relapse/Rejection-Free Survival and Similar Outcome of Related and Unrelated Allogeneic Stem Cell Transplantation for Aplastic Anemia: A Nationwide Swedish Cohort Study

Vaht, Krista; Goransson, Magnus; Carlson, Kristina; Isaksson, Cecilia et al.

Ingår i Biology of blood and marrow transplantation, s. 1970-1974, 2019

• DOI för High Graft-versus-Host Disease-Free, Relapse/Rejection-Free Survival and Similar Outcome of Related and Unrelated Allogeneic Stem Cell Transplantation for Aplastic Anemia: A Nationwide Swedish Cohort Study

Family Mismatched Allogeneic Stem Cell Transplantation for Myelofibrosis: Report from the Chronic Malignancies Working Party of European Society for Blood and Marrow Transplantation

Raj, Kavita; Eikema, Diderik-Jan; McLornanl, Donal P.; Olavarria, Eduardo et al.

Ingår i Biology of blood and marrow transplantation, s. 522-528, 2019

• DOI för Family Mismatched Allogeneic Stem Cell Transplantation for Myelofibrosis: Report from the Chronic Malignancies Working Party of European Society for Blood and Marrow Transplantation

Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial

Burt, Richard K.; Balabanov, Roumen; Burman, Joachim; Sharrack, Basil et al.

Ingår i Journal of the American Medical Association (JAMA), s. 165-174, 2019

• DOI för Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial

Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT

McLornan, Donal P.; Szydlo, Richard; Robin, Marie; van Biezen, Anja et al.

Ingår i British Journal of Haematology, s. 418-422, 2018

• DOI för Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT

Health-related quality of life in multiple myeloma patients with first relapse treated with Carfilzomib-based re-induction and salvage autologous stem cell transplantation: data from a Nordic phase II trial

Eshoj, Henrik Rode; Nielsen, Lene Kongsgaard; Schjesvold, Fredrik; Abildgaard, Niels et al.

Ingår i Quality of Life Research, 2018

• DOI för Health-related quality of life in multiple myeloma patients with first relapse treated with Carfilzomib-based re-induction and salvage autologous stem cell transplantation: data from a Nordic phase II trial

Low response rate to ATG-based immunosuppressive therapy in very severe aplastic anaemia A Swedish nationwide cohort study

Vaht, Krista; Goransson, Magnus; Carlson, Kristina; Isaksson, Cecilia et al.

Ingår i European Journal of Haematology, s. 613-620, 2018

• DOI för Low response rate to ATG-based immunosuppressive therapy in very severe aplastic anaemia A Swedish nationwide cohort study

Outcome and survival of myeloma patients diagnosed 2008-2015. Real world data on 4904 patients from the Swedish Myeloma Registry (SMR)

Blimark, Cecilie Hveding; Turesson, Ingemar; Genell, Anna; Ahlberg, Lucia et al.

Ingår i Haematologica, s. 506-513, 2018

• DOI för Outcome and survival of myeloma patients diagnosed 2008-2015. Real world data on 4904 patients from the Swedish Myeloma Registry (SMR)

Autologous hematopoietic stem cell transplantation for pediatric multiple sclerosis: a registry-based study of the Autoimmune Diseases Working Party (ADWP) and Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Burman, Joachim; Kirgizov, K; Carlson, Kristina; Badoglio, M et al.

Ingår i Bone Marrow Transplantation, s. 1133-1137, 2017

• DOI för Autologous hematopoietic stem cell transplantation for pediatric multiple sclerosis: a registry-based study of the Autoimmune Diseases Working Party (ADWP) and Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Family mismatched allogeneic stem cell transplantationfor myelofibrosis: Report from the chronic malignancies working party of EBMT

Raj, K.; Olavarria, E.; Eikema, D-J; Blok, H-J et al.

Ingår i Bone Marrow Transplantation, 2017

• DOI för Family mismatched allogeneic stem cell transplantationfor myelofibrosis: Report from the chronic malignancies working party of EBMT

Allogeneic Hematopoietic Stem Cell Transplantation Provides Cure for Adult Patients with Hemophagocytic Lymphohistiocytosis (HLH): A Retrospective Study of The Chronic Malignancies and Inborn ErrorsWorking Parties (CMWP and IEWP) of The EBMT

Machowcz, Rafal; Suarez, Felipe; Wiktor-Jedrzejczak, Wieslaw; Eikema, Diderik-Jan et al.

Ingår i Pediatric Blood & Cancer, 2017

Incidence and outcome of acquired aplastic anemia: real-world data from patients diagnosed in Sweden from 2000-2011

Vaht, Krista; Goransson, Magnus; Carlson, Kristina; Isaksson, Cecilia et al.

Ingår i Haematologica, s. 1683-1690, 2017

• DOI för Incidence and outcome of acquired aplastic anemia: real-world data from patients diagnosed in Sweden from 2000-2011
• Ladda ner fulltext (pdf) av Incidence and outcome of acquired aplastic anemia: real-world data from patients diagnosed in Sweden from 2000-2011

Incidence, characteristics, and outcome of solitary plasmacytoma and plasma cell leukemia. Population-based data from the Swedish Myeloma Register

Nahi, Hareth; Genell, Anna; Walinder, Goran; Uttervall, Katarina et al.

Ingår i European Journal of Haematology, s. 216-222, 2017

• DOI för Incidence, characteristics, and outcome of solitary plasmacytoma and plasma cell leukemia. Population-based data from the Swedish Myeloma Register

Successful autologous haematopoietic stem cell transplantation for refractory myasthenia gravis - a case report

Håkansson, Irene; Sandstedt, Anna; Lundin, Fredrik; Askmark, Håkan et al.

Ingår i Neuromuscular Disorders, s. 90-93, 2017

• DOI för Successful autologous haematopoietic stem cell transplantation for refractory myasthenia gravis - a case report

Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation in Sweden, long-term results from all patients treated in 1994-2009.

Rosengren, Sara; Mellqvist, U-H; Nahi, H; Forsberg, K et al.

Ingår i Bone Marrow Transplantation, s. 1569-1572, 2016

• DOI för Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation in Sweden, long-term results from all patients treated in 1994-2009.

Autologous hematopoietic stem cell transplantation in neuromyelitis optica: A registry study of the EBMT Autoimmune Diseases Working Party

Greco, Raffaella; Bondanza, Attilio; Oliveira, Maria Carolina; Badoglio, Manuela et al.

Ingår i Multiple Sclerosis Journal, s. 189-197, 2015

• DOI för Autologous hematopoietic stem cell transplantation in neuromyelitis optica: A registry study of the EBMT Autoimmune Diseases Working Party

Second allogeneic stem cell transplant for aplastic anaemia: a retrospective study by the severe aplastic anaemia working party of the European society for blood and marrow transplantation

Cesaro, Simone; de latour, Regis Peffault; Tridello, Gloria; Pillon, Marta et al.

Ingår i British Journal of Haematology, s. 606-614, 2015

• DOI för Second allogeneic stem cell transplant for aplastic anaemia: a retrospective study by the severe aplastic anaemia working party of the European society for blood and marrow transplantation

Improved survival in myeloma patients: starting to close in on the gap between elderly patients and a matched normal population

Liwing, Johan; Uttervall, Katarina; Lund, Johan; Aldrin, Anders et al.

Ingår i British Journal of Haematology, s. 684-693, 2014

• DOI för Improved survival in myeloma patients: starting to close in on the gap between elderly patients and a matched normal population

Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience

Burman, Joachim; Iacobaeus, Ellen; Svenningsson, Anders; Lycke, Jan et al.

Ingår i Journal of Neurology, Neurosurgery and Psychiatry, s. 1116-1121, 2014

• DOI för Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience

Evaluation of patients with cardiac amyloidosis using echocardiography, ECG and right heart catheterization

Granstam, Sven-Olof; Rosengren, Sara; Vedin, Ola; Kero, Tanja et al.

Ingår i Amyloid, s. 27-33, 2013

• DOI för Evaluation of patients with cardiac amyloidosis using echocardiography, ECG and right heart catheterization

In Vivo Visualization of Amyloid Deposits in the Heart with ¹¹C-PIB and PET

Antoni, Gunnar; Lubberink, Mark; Estrada, Sergio; Axelsson, Jan et al.

Ingår i Journal of Nuclear Medicine, s. 213-220, 2013

• DOI för In Vivo Visualization of Amyloid Deposits in the Heart with ¹¹C-PIB and PET

Plerixafor and granulocyte colony-stimulating factor for first-line steady-state autologous peripheral blood stem cell mobilization in lymphoma and multiple myeloma: results of the prospective PREDICT trial

Russell, Nigel; Douglas, Kenny; Ho, Anthony; Mohty, Mohamad et al.

Ingår i Haematologica, s. 172-178, 2013

• DOI för Plerixafor and granulocyte colony-stimulating factor for first-line steady-state autologous peripheral blood stem cell mobilization in lymphoma and multiple myeloma: results of the prospective PREDICT trial

A Combination Regimen of Bortezomib, Cyclophosphamide and Betamethasone Gives Quicker, Better and More Durable Response than VAD/CyBet Regimens: Results from a Swedish Retrospective Analysis

Uttervall, Katarina; Admasie, Johannes; Alici, Evren; Lund, Johan et al.

Ingår i Acta Haematologica, s. 7-15, 2013

• DOI för A Combination Regimen of Bortezomib, Cyclophosphamide and Betamethasone Gives Quicker, Better and More Durable Response than VAD/CyBet Regimens: Results from a Swedish Retrospective Analysis

New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation

Daikeler, Thomas; Labopin, Myriam; Ruggeri, Annalisa; Crotta, Alessandro et al.

Ingår i Blood, s. 1059-1064, 2013

• DOI för New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation

Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMT

Jantunen, Esa; Boumendil, Ariane; Finel, Herve; Luan, Jian-Jian et al.

Ingår i Blood, s. 2529-2532, 2013

• DOI för Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMT

Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial

Mellqvist, Ulf-Henrik; Gimsing, Peter; Hjertner, Oyvind; Lenhoff, Stig et al.

Ingår i Blood, s. 4647-4654, 2013

• DOI för Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial

Thalidomide and dexamethasone vs. bortezomib and dexamethasone for melphalan refractory myeloma: a randomized study

Hjorth, Martin; Hjertner, Oyvind; Knudsen, Lene Meldgaard; Gulbrandsen, Nina et al.

Ingår i European Journal of Haematology, s. 485-496, 2012

• DOI för Thalidomide and dexamethasone vs. bortezomib and dexamethasone for melphalan refractory myeloma: a randomized study

Is Multiple Myeloma a Chronic Disease?: A Population Based Study Comparing 1843 Patients to a Matched Swedish Population

Nahi, Hareth; Liwing, Johan; Aldrin, Anders; Andreasson, Johan et al.

Ingår i Blood, s. 2970, 2012

Mandibular osteomyelitis associated with paroxysmal nocturnal hemoglobinuria

Kharazmi, M; Carlson, Kristina; Björnstad, L; Petersson, A et al.

Ingår i International Journal of Oral and Maxillofacial Surgery, s. 1441-1444, 2011

• DOI för Mandibular osteomyelitis associated with paroxysmal nocturnal hemoglobinuria

Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma

Waage, Anders; Gimsing, Peter; Fayers, Peter; Abildgaard, Niels et al.

Ingår i Blood, s. 1405-1412, 2010

• DOI för Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma

Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial

Gimsing, Peter; Carlson, Kristina; Turesson, Ingemar; Fayers, Peter et al.

Ingår i The Lancet Oncology, s. 973-982, 2010

• DOI för Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial

Population-based incidence, prevalence and survival of systemic AL amyloidosis in Sweden

Rosengren, Sara; Thelander, Ulrika; Mattsson, Mattias; Carlson, Kristina